5/17/2021State Council Approves Cross-border Retail e-Commerce Trial for Import...

5/17/2021Everest Med's BLA for Sacituzumab Govitecan-Hziy Accepted in China 

5/17/2021Iconovo Extends Deal with Amneal for Generic Symbicort to Cover Key Ma...

5/17/2021Lilly/Innovent File U.S. BLA for Sintilimab in Combo with Pemetrexed a...

5/13/2021NMPA Issues the Guidelines for Pharmacovigilance Quality Control

5/12/2021CDE Solicits Comments on the Guidelines for Clinical Trial Protocol De...

5/12/2021IQVIA: Chinese Hospital Drug Market Down 10.7% in 2020

5/12/2021Citrine and Diurnal Enter Partnership to Pring Efmody to China for...

5/11/2021Sumitomo Dainippon and Sinovant Enter License Pact for Select Asian Pr...

5/11/2021IQVIA's New Report: Global Medicine Spending and Usage Trends: Outlook...

5/10/2021NHSA and NHC Issues Policy Document for "Twin-Channel" Mechanism of Ne...

5/8/2021WHO Approves China's Sinopharm Vaccine for Emergency Use

5/8/2021Amphastar to Restructure Its Chinese Subsidiaries

5/8/2021JPO Officially Initiates Information Submission for the 5th Round of N...

5/7/2021Asieris and BeiGene Enter into Clinical Collaboration to Evaluate Comb...

5/7/2021WuXi Biologics Completed Three Acquisitions to Enhance its Global Netw...

5/7/2021Recent Executive Moves

4/30/2021CROs dMed and Clinipace Merge to Accelerate Customer Success

4/30/2021Sirnaomics Enters Partnership with Walvax to Co-Develop Its Antiviral ...

4/30/2021Financial-related Company News in Brief

4/30/2021Recent Official and Executive Moves

4/29/2021Sanofi Reports China Sales Growth amid Dupixent's Launch in the Countr...

4/29/2021Top 20 Listed Chinese Pharmaceutical Companies by R&D Spending 2020

4/29/2021PhIIC: Performance Review of Drug Products Included in the NRDL throug...

4/28/2021Shanghai Launches Customized BMI Supplemental Health Insurance as the ...

4/27/2021I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulc...

4/27/2021BioPlan: Chinese CDMO Sector Growing but Unlikely To Make Global Impac...

4/27/2021Simcere Pharma Ditches Cell Therapy to Focus on Oncology

4/26/2021SMEI: Review of Chinese Terminal Drug Markets in 2011 - 2020

4/23/2021Hua Medicine Files Chinese NDA for Dorzagliatin

Page:94/360 Total number of articles:10786: [First][<<] [92] [93] [94] [95] [96] [>>] [End]